Variant report

Variant	esv3433216
Chromosome Location	chr4:7523752-7525700
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr4:7516846..7519696-chr4:7521879..7524111,2	K562	blood:
2	chr4:7524802..7527211-chr4:7527477..7529278,2	MCF-7	breast:
3	chr4:7524845..7525381-chr4:7721481..7722229,2	K562	blood:

Extended variants
information (count: 121 )
Associated
traits (count: 54 )

Variant overlapped rSNPs/rCNVs (count:121 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs565050342	chr4:7523789-7523790	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs148033661	chr4:7523820-7523821	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs141737828	chr4:7523821-7523822	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs559874890	chr4:7523832-7523833	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs530249848	chr4:7523846-7523847	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs111296468	chr4:7523859-7523860	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs77946862	chr4:7523881-7523882	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs75565140	chr4:7523890-7523891	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs531202570	chr4:7523904-7523905	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs61096498	chr4:7523906-7523907	Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs570981077	chr4:7523922-7523923	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs368379576	chr4:7523923-7523924	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs534886027	chr4:7523966-7523967	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs553192634	chr4:7523994-7523995	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs565423760	chr4:7524043-7524044	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs535962773	chr4:7524085-7524086	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs73214614	chr4:7524089-7524090	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs150840873	chr4:7524101-7524102	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs542600617	chr4:7524104-7524105	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs78461790	chr4:7524135-7524136	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs11931772	chr4:7524138-7524139	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs138229297	chr4:7524139-7524140	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs559613928	chr4:7524164-7524165	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs542508476	chr4:7524206-7524207	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs576130747	chr4:7524240-7524241	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs180961687	chr4:7524268-7524269	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs542360654	chr4:7524290-7524291	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs28577242	chr4:7524298-7524299	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs10017620	chr4:7524310-7524311	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs9995830	chr4:7524315-7524316	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs565353292	chr4:7524329-7524330	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs532723589	chr4:7524388-7524389	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs528794957	chr4:7524423-7524424	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs201191892	chr4:7524442-7524443	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs11731369	chr4:7524448-7524449	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs200505002	chr4:7524472-7524473	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs568330504	chr4:7524484-7524485	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs535903304	chr4:7524485-7524486	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs547982214	chr4:7524488-7524489	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs539565706	chr4:7524494-7524495	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs184544310	chr4:7524531-7524532	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs11728487	chr4:7524542-7524543	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs116030491	chr4:7524560-7524561	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs111216362	chr4:7524565-7524566	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs36231941	chr4:7524607-7524608	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs139651153	chr4:7524621-7524622	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs62644743	chr4:7524622-7524623	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs142353027	chr4:7524623-7524624	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs116328480	chr4:7524627-7524628	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs62635993	chr4:7524631-7524632	Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:54)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Melanoma	20688739	CNVD
Colorectal cancer	16272173	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Breast cancer	21509527	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Schizophrenia	22241247	CNVD
Autosomal-dominant microtia	18179897	CNVD
Glioma	17123091	CNVD
Colorectal cancer	20459617	CNVD
Breast cancer	17133270	CNVD
Melanoma	20877625	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:25 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:7520000-7524400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
2	chr4:7520200-7525400	Bivalent Enhancer	Fetal Muscle Leg	muscle
3	chr4:7520400-7524600	Enhancers	Fetal Brain Male	brain
4	chr4:7521000-7527600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
5	chr4:7522800-7523800	Weak transcription	Brain Germinal Matrix	brain
6	chr4:7523600-7523800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
7	chr4:7523600-7524000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
8	chr4:7523600-7524800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr4:7523800-7525800	Enhancers	Brain Germinal Matrix	brain
10	chr4:7524000-7525200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
11	chr4:7524200-7524800	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
12	chr4:7524200-7525000	Bivalent Enhancer	Fetal Brain Female	brain
13	chr4:7524400-7524800	Bivalent/Poised TSS	Breast Myoepithelial Primary Cells	Breast
14	chr4:7524600-7525200	Bivalent Enhancer	Fetal Brain Male	brain
15	chr4:7524800-7525000	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr4:7524800-7525000	Bivalent Enhancer	Fetal Stomach	stomach
17	chr4:7524800-7527400	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
18	chr4:7525000-7526200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr4:7525000-7526800	Bivalent Enhancer	HepG2	liver
20	chr4:7525200-7526800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
21	chr4:7525200-7527000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
22	chr4:7525600-7526000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr4:7525600-7526600	Enhancers	Primary T killer memory cells from peripheral blood	blood
24	chr4:7525600-7526800	Enhancers	Primary T helper cells fromperipheralblood	blood
25	chr4:7525600-7527200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links